STP1002

· ST Pharm Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for STP1002, covering 2024-07-03 to 2024-07-03. Get the full timeline:

Most recent: Clinical Trial Update: First-In-Human Dose-Escalation Study of STP1002 in Patients With Advanced-Stage Solid Tumors [Phase 1]